Edmond de Rothschild (Suisse)’s Ocular Therapeutix OCUL Stock Holding History

Edmond de Rothschild (Suisse)’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$481K	Hold	70,000	–	–	0.15%	134
2016 Q2	$346K	Buy	70,000 +25,000	+56%	+$248K	0.11%	143
2016 Q1	$435K	Hold	45,000	–	–	0.18%	108
2015 Q4	$422K	Buy	45,000 +18,000	+67%	+$194K	0.16%	98
2015 Q3	$380K	Buy	+27,000	New	+$543K	0.13%	113

Other funds holding OCUL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

Edmond de Rothschild (Suisse)'s OCUL Position: Q3 2016 in Review

Edmond de Rothschild (Suisse) held its Ocular Therapeutix (OCUL) position steady in Q3 2016 at 70,000 shares worth $481K. The position accounts for 0.15% of the portfolio, ranked #134.

Edmond de Rothschild (Suisse) first reported a position in OCUL in Q3 2015 and has held it in 5 quarters since. 72 funds tracked by Wall St. Rank hold OCUL as of Q3 2016.

Edmond de Rothschild (Suisse) held 70,000 shares of Ocular Therapeutix worth $481K as of Q3 2016.
Edmond de Rothschild (Suisse) left its Ocular Therapeutix share count unchanged in Q3 2016.
Ocular Therapeutix made up 0.15% of Edmond de Rothschild (Suisse)'s portfolio in Q3 2016, its #134 holding.
Edmond de Rothschild (Suisse) first reported a position in Ocular Therapeutix in Q3 2015 and has held it in 5 quarters since.
72 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2016.

Based on Edmond de Rothschild (Suisse)'s 13F filing for Q3 2016, filed 14 Nov 2016.